Sintx Technologies, Inc. (SINT)
USD 2.01
(-19.6%)
USD 2.01
(-19.6%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.68 Million USD | 85.37% |
| 2022 | 1.98 Million USD | 4.79% |
| 2021 | 1.89 Million USD | 7.6% |
| 2020 | 1.76 Million USD | -6.12% |
| 2019 | 1.87 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 3.06 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 39.12 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 3.54 Million USD | 0.0% |
| 2024 Q2 | 3.42 Million USD | 0.0% |
| 2023 Q3 | 1.04 Million USD | -23.16% |
| 2023 Q1 | 1.58 Million USD | -20.56% |
| 2023 Q2 | 1.36 Million USD | -13.92% |
| 2023 Q4 | 3.68 Million USD | 252.82% |
| 2023 FY | 3.68 Million USD | 85.37% |
| 2022 FY | 1.98 Million USD | 4.79% |
| 2022 Q4 | 1.98 Million USD | 5.63% |
| 2022 Q1 | 1.76 Million USD | -7.11% |
| 2022 Q3 | 1.88 Million USD | -9.25% |
| 2022 Q2 | 2.07 Million USD | 17.7% |
| 2021 Q2 | 1.74 Million USD | -7.49% |
| 2021 Q4 | 1.89 Million USD | -23.31% |
| 2021 FY | 1.89 Million USD | 7.6% |
| 2021 Q3 | 2.47 Million USD | 42.16% |
| 2021 Q1 | 1.88 Million USD | 6.69% |
| 2020 Q1 | 1.79 Million USD | -4.63% |
| 2020 FY | 1.76 Million USD | -6.12% |
| 2020 Q2 | 1.92 Million USD | 7.31% |
| 2020 Q4 | 1.76 Million USD | 1.5% |
| 2020 Q3 | 1.73 Million USD | -9.62% |
| 2019 Q4 | 1.87 Million USD | -4.81% |
| 2019 FY | 1.87 Million USD | 0.0% |
| 2019 Q3 | 1.97 Million USD | -3.71% |
| 2019 Q2 | 2.05 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q3 | 33 Thousand USD | -92.96% |
| 2016 Q4 | - USD | -100.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q2 | 469 Thousand USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | 2.77 Million USD | -10.64% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q1 | 3.11 Million USD | 1.6% |
| 2015 FY | - USD | -100.0% |
| 2014 Q2 | 1.21 Million USD | 0.0% |
| 2014 Q3 | 3.71 Million USD | 205.76% |
| 2014 Q4 | 3.06 Million USD | -17.67% |
| 2014 FY | 3.06 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | -100.0% |
| 2011 FY | 39.12 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 89.787% |
| BrainsWay Ltd. | 239 Thousand USD | -1442.678% |
| Cerus Corporation | 59.79 Million USD | 93.834% |
| Envoy Medical, Inc. | 404 Thousand USD | -812.624% |
| electroCore, Inc. | 537 Thousand USD | -586.592% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -30625.0% |
| IceCure Medical Ltd | 376 Thousand USD | -880.585% |
| Inogen, Inc. | 18.27 Million USD | 79.819% |
| OrthoPediatrics Corp. | 13.45 Million USD | 72.606% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -1752.764% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -913.681% |
| MaxCyte, Inc. | 17.96 Million USD | 79.481% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -6569.199% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 96.04% |
| PAVmed Inc | 2.96 Million USD | -24.561% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 40.666% |
| RxSight, Inc. | 1.21 Million USD | -204.459% |
| Sight Sciences, Inc. | 31.7 Million USD | 88.372% |
| SI-BONE, Inc. | 36.06 Million USD | 89.777% |
| TELA Bio, Inc. | 40.51 Million USD | 90.9% |
| Treace Medical Concepts, Inc. | 53 Million USD | 93.044% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -142.406% |
| Acutus Medical, Inc. | 32.65 Million USD | 88.709% |
| Talis Biomedical Corporation | 16.78 Million USD | 78.035% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 8.85% |
| CVRx, Inc. | 30.38 Million USD | 87.865% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -262.562% |
| Bioventus Inc. | 366.99 Million USD | 98.995% |
| Venus Concept Inc. | 70.79 Million USD | 94.792% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -196.383% |
| LivaNova PLC | 568.54 Million USD | 99.352% |
| 908 Devices Inc. | 3.92 Million USD | 6.159% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.279% |
| Nemaura Medical Inc. | 3.08 Million USD | -19.411% |
| NeuroPace, Inc. | 56.95 Million USD | 93.526% |
| LENSAR, Inc. | 1.75 Million USD | -110.686% |
| Apyx Medical Corporation | 33.18 Million USD | 88.89% |
| Cutera, Inc. | 418.69 Million USD | 99.119% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 75.492% |
| BioSig Technologies, Inc. | 103 Thousand USD | -3479.612% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 86.296% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 62.941% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.752% |
| Axonics, Inc. | 25.84 Million USD | 85.731% |
| Outset Medical, Inc. | 134.59 Million USD | 97.261% |
| IRIDEX Corporation | 1.75 Million USD | -110.565% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 92.818% |
| IRadimed Corporation | 1.61 Million USD | -128.286% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -1994.886% |
| INVO Bioscience, Inc. | 6.77 Million USD | 45.588% |
| Telesis Bio, Inc. | 5.26 Million USD | 30.025% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 38.255% |
| Varex Imaging Corporation | 464.2 Million USD | 99.206% |
| Quipt Home Medical Corp. | 60.82 Million USD | 93.938% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -527.041% |
| Pulmonx Corporation | 35.08 Million USD | 89.492% |
| Dynatronics Corporation | 3.25 Million USD | -13.151% |
| Modular Medical, Inc. | 817 Thousand USD | -351.285% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -2341.722% |
| Semler Scientific, Inc. | 70 Thousand USD | -5167.143% |
| InMode Ltd. | 6.61 Million USD | 44.246% |
| Bruker Corporation | 1.14 Billion USD | 99.678% |
| Cytosorbents Corporation | 2.54 Million USD | -44.994% |
| DexCom, Inc. | 2.57 Billion USD | 99.857% |
| Align Technology, Inc. | 96.96 Million USD | 96.198% |
| Viveve Medical, Inc. | 5.12 Million USD | 28.044% |
| ZimVie Inc. | 508.79 Million USD | 99.275% |
| Movano Inc. | 15.00 USD | -24579900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 79.658% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.075% |
| Profound Medical Corp. | 4.97 Million USD | 25.881% |
| Insulet Corporation | 1.36 Billion USD | 99.73% |
| enVVeno Medical Corporation | 1.06 Million USD | -246.523% |
| Surmodics, Inc. | 29.4 Million USD | 87.461% |
| iCAD, Inc. | 273 Thousand USD | -1250.549% |
| Nuwellis, Inc. | 221 Thousand USD | -1568.326% |
| Biotricity, Inc. | 10.85 Million USD | 66.037% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 89.451% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -467.448% |
| InspireMD, Inc. | 1.03 Million USD | -255.202% |
| PAVmed Inc. | 2.96 Million USD | -24.561% |
| BIOLASE, Inc. | 13.98 Million USD | 73.636% |
| Beyond Air, Inc. | 14.72 Million USD | 74.954% |
| FONAR Corporation | 37.92 Million USD | 90.279% |
| AxoGen, Inc. | 46.6 Million USD | 92.088% |
| Vivani Medical, Inc. | 19.31 Million USD | 80.909% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 91.735% |
| Inari Medical, Inc. | 30.35 Million USD | 87.854% |
| UFP Technologies, Inc. | 28 Million USD | 86.832% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -749.451% |
| Tenon Medical, Inc. | 428 Thousand USD | -761.449% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -267.964% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -71.315% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.824% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 90.095% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -527.041% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -518.624% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.587% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.272% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -507.414% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -3886.592% |
| Hyperfine, Inc. | 64 Thousand USD | -5660.938% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 98.047% |
| Biomerica, Inc. | 459 Thousand USD | -703.268% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -720.276% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -1840.659% |
| Silk Road Medical, Inc | 75.62 Million USD | 95.125% |